நோவா நாசர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MedCity News Serimmune CEO: Leveraging the functional antibody repertoire will transform healthcare In response to emailed questions, the CEO and CTO talk about the immune intelligence startups Human Immunity Map a growing database of immune interactions that can support the development of multiplex diagnostics, vaccines and therapeutics. Shares0 Serimmune CEO Noah Nasser and CTO John Shon discussed the capabilities of the immune intelligence startup intended to aid in the development of diagnostics, vaccines, and therapeutics. What is Serimmune? Serimmune is an immune intelligence company devoted to placing the power and complexity of personal antibody response in the hands of consumers, patients, clinicians and researchers. Serimmune’s proprietary technology identifies and exploits the universe of relationships between antibodies and antigens. The company’s proprietary technology, Serum Epitope Repertoire Analysis (SERA), provides a holistic view of an individual’s

United statesSan diegoNoah nasserJohn shonSerum epitope repertoire analysisHuman immunity mapChief commercial officerHuman longevityLyme diseaseUsing serimmuneஒன்றுபட்டது மாநிலங்களில்சான் டியாகோநோவா நாசர்ஜான் ஷோன்தலைமை வணிகரீதியானது அதிகாரிமனிதன் நீண்ட ஆயுள்